Featured Research

from universities, journals, and other organizations

Young people with type 1 diabetes at risk for heart disease, research shows

Date:
June 26, 2011
Source:
University of Colorado Denver
Summary:
New research shows that adolescents and young adults with type 1 (juvenile) diabetes have thicker and stiffer carotid arteries, also known as atherosclerosis, a risk factor for heart attack and stroke in adults. This research is believed to be the first to examine whether type 1 diabetes has a measurable effect on carotid arteries in this age group.

New research shows that adolescents and young adults with type 1 (juvenile) diabetes have thicker and stiffer carotid arteries, also known as atherosclerosis, a risk factor for heart attack and stroke in adults. This research is believed to be the first to examine whether type 1 diabetes has a measurable effect on carotid arteries in this age group.

The research is part of The SEARCH CVD Study, a collaborative effort between investigators at the Colorado School of Public Health and the Cincinnati Children's Hospital Medical Center. Dana Dabelea, MD, PhD, an epidemiologist at the University of Colorado and principal investigator said "We hope that the knowledge provided by the research study will translate into better quality of care and better quality of life for youth with type 1 diabetes and will reduce the burden of cardiovascular disease in this patient population."

Elaine Urbina, MD, a cardiologist at Cincinnati Children's Hospital Medical Center, will present the research at the meeting of the American Diabetes Association in San Diego on June 27. "We have new tools for early identification of cardiac and arterial problems in people with type 1 diabetes," says Dr. Urbina. "This means we can intensify therapy to improve glycemic control and reduce cardiovascular risk factors, especially obesity, thereby improving cardiovascular outcomes in people with type 1 diabetes.

The researchers studied 162 people between the ages of 17 and 23. Seventy-eight percent had type 1 diabetes and the remainder were the control group. After adjusting for age, race, sex and lipids, people with type 1diabetes had both thicker and stiffer carotids than the control group.

SEARCH CVD (RO1DK078542) is funded by the National Institutes of Health and is an ancillary study of the SEARCH for Diabetes in Youth study, a multi-center study funded by the Centers for Disease Control and Prevention and the National Institute of Diabetes and Digestive and Kidney Diseases.


Story Source:

The above story is based on materials provided by University of Colorado Denver. Note: Materials may be edited for content and length.


Cite This Page:

University of Colorado Denver. "Young people with type 1 diabetes at risk for heart disease, research shows." ScienceDaily. ScienceDaily, 26 June 2011. <www.sciencedaily.com/releases/2011/06/110624182307.htm>.
University of Colorado Denver. (2011, June 26). Young people with type 1 diabetes at risk for heart disease, research shows. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/06/110624182307.htm
University of Colorado Denver. "Young people with type 1 diabetes at risk for heart disease, research shows." ScienceDaily. www.sciencedaily.com/releases/2011/06/110624182307.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins